Birth gestational age, weeks (mean, SD)
|
28.89 (2.02) |
26.82 (2.45) |
<.0001 |
23 weeks (n, %)
|
3 (0.8) |
18 (7.8) |
<.00001 |
24 weeks (n, %)
|
13 (3.7) |
30 (13.0) |
<.00001 |
25 weeks (n, %)
|
13 (3.7) |
27 (11.7) |
.0002 |
26 weeks (n, %)
|
17 (4.8) |
39 (17.0) |
<.00001 |
27 weeks (n, %)
|
33 (9.3) |
24 (10.4) |
.666 |
28 weeks (n, %)
|
45 (12.7) |
25 (10.9) |
.495 |
29 weeks (n, %)
|
62 (17.6) |
28 (12.2) |
.078 |
30 weeks (n, %)
|
88 (24.9) |
18 (7.8) |
<.00001 |
31 weeks (n, %)
|
66 (18.7) |
16 (7.0) |
.0001 |
32 weeks (n, %)
|
13 (3.7) |
4 (1.7) |
.173 |
Birth weight, grams (mean, SD)
|
1214.54 (323.82) |
967.80 (348.39) |
<.0001 |
Male/Total (n, %)
|
194 (55.0) |
123 (53.5) |
.726 |
Race (n, %):
|
|
|
.030 |
Black
|
47 (13.3) |
46 (20.0) |
|
White
|
284 (80.5) |
168 (73.0) |
|
Asian
|
14 (4.0) |
5 (2.2) |
|
Other
|
8 (2.3) |
11 (4.8) |
|
Rate of antenatal steroids (n, %)
|
332 (94.1) |
205 (89.1) |
.031 |
Bacterial sepsis, on or before DOL3 (n, %)
|
3 (0.8) |
3 (1.3) |
.595 |
Sepsis or meningitis, late after DOL3 (n, %)
|
Bacterial (n, %)
|
10 (2.8) |
30 (13.0) |
<.00001 |
Coagulase negative staph (n, %)
|
6 (1.7) |
7 (3.0) |
.283 |
Fungal (n, %)
|
1 (0.3) |
2 (0.9) |
.333 |
Any respiratory support at 36 weeks (Chronic Lung disease)
(n, %)
|
67 (19.0) |
98 (42.6) |
<.00001 |
Mechanical ventilation
|
3 (0.8) |
7 (3.0) |
.046 |
High frequency oscillatory ventilation
|
1 (0.3) |
0 |
.419 |
High flow nasal canula
|
18 (5.1) |
47 (20.4) |
<.00001 |
Noninvasive positive pressure ventilation
|
5 (1.4) |
8 (3.5) |
.099 |
Continuous positive airway pressure
|
8 (2.3) |
6 (2.6) |
.792 |
Oxygen at discharge
|
31 (8.8) |
48 (20.9) |
<.00001 |
Steroids for chronic lung disease (n, %)
|
28 (7.9) |
58 (25.2) |
<.00001 |
Necrotizing enterocolitis (NEC) (n, %)
|
20 (5.7) |
19 (8.3) |
.220 |
Surgery for NEC, suspected NEC, or bowel perforation (n,
%)
|
5 (1.4) |
10 (4.3) |
.029 |
Hypoxic-ischemic encephalopathy (n, %)
|
0 |
0 |
|